Clinical relevance of circulating cell-free microRNAs in ovarian cancer - Wikidata - awgldk - TriplyDB

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

http://www.wikidata.org/entity/Q26747154

about

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective The Unique Molecular and Cellular Microenvironment of Ovarian Cancer Prediction of therapy response in ovarian cancer: Where are we now?The role of biomarkers in the management of epithelial ovarian cancer.Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.miRNAs and ovarian cancer: An overview.Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer.Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease.Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer.miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer.Revisiting ovarian cancer microenvironment: a friend or a foe?Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.miR-423-5p serves as a diagnostic indicator and inhibits the proliferation and invasion of ovarian cancer.Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors Integrated extracellular microRNA profiling for ovarian cancer screening Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

P2860

Q28066904-4EB87057-07CC-4CE0-B92B-B6070C9F9CB8 Q33738954-4E2511C4-C0CD-4C00-B5E0-D68B857CAD06 Q33829967-F9355B57-09E7-4646-8545-C56C738E0662 Q37584834-BF087545-0DB2-44DC-93C1-8A0AF8F9457F Q38432883-08AEB24D-A42F-4754-99F2-9A6480403249 Q38649539-290D7393-D0D9-4E70-A744-F4AB2B4C20CE Q39169603-C61AA758-BB77-4EAC-923F-3B5A42C65975 Q39263260-9D897149-9F19-420C-BA9C-645BF9090C81 Q39281140-B86D6D23-D5A1-4023-BA70-349AB8CE6DE1 Q39391417-6A6EE685-BA03-4F91-ABCD-F125262DAFB5 Q39432311-5BBD4AB0-6711-4D29-ADBF-B193BA63A1F7 Q41346578-A9A50C72-3783-45E3-8ED1-6616F841B487 Q42155203-4D46B9F5-87D3-4B30-9D5B-1BE99A806BAC Q45944325-CA461777-DDAE-458D-BC9B-BD9B7A7B35AD Q47114745-42ABDCD4-B465-49FA-8460-1021B83AE702 Q47773956-48D827F7-8D83-423C-9889-1FD8CDEF7427 Q52941950-C866B99A-47CC-4B9E-9681-F50CDCD02005 Q54965683-D7444097-6F4F-4F67-B4FB-64C49833F19F Q57158952-838E6526-32E0-4D51-9D61-DC7C22A9F3A9 Q58547195-EA656DB0-6431-45DB-85D7-E6D3D882E652 Q58609457-3C2E76EC-F6D1-458C-9AED-731633A1D0E3 Q58737912-941996CF-C5C5-4CB7-9942-8F6C1BB8C044

P2860

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

http://www.wikidata.org/entity/Q26747154

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@ast

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@en

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@nl

type

label

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@ast

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@en

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@nl

prefLabel

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@ast

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@en

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@nl

P1433

Q26747154-F9F41A2B-7810-4A4C-819D-52FA9C53C8D7

P1476

Q26747154-DF3D4CD3-A2A0-409F-AC3D-068877D45315

P2093

Q26747154-1CB6B68C-721F-47BA-AEA2-E44E09E8315B

Q26747154-2B13188D-2FF7-464F-A65B-5BD1E42AF8E8

Q26747154-33D53136-2FB5-46EB-A92F-DDD9B8A67832

Q26747154-46AC45D9-5CA0-4DA5-937F-B45C281C6D43

Q26747154-92B54CCC-E080-4A95-8074-43C4891F8794

Q26747154-F65A3AA9-DC8C-41F7-9B7E-CBA4F3BFFA86

P275

Q26747154-CE48765B-EA1B-4365-A3E6-79FDA9F28562

P2860

Q26747154-06C159B1-DD35-43EA-9EC2-72F7466B626D

Q26747154-0941D15B-56F4-4DCF-B8CC-0771C1400E10

Q26747154-0C7B467F-031F-4849-AC35-A3EEC60C0D38

Q26747154-17D2C2F7-6ABF-48A0-AC72-9422A27E1458

Q26747154-18D3032B-978F-482C-94C6-FEDAFD7B78AD

Q26747154-1B63C359-FDBD-4DE9-AAB4-C1D0DEFC4886

Q26747154-1D1243C5-E4F6-4494-834C-0AF75FE472DC

Q26747154-1D5EEE30-4596-44BE-B7A9-15F60F5D4C8F

Q26747154-207E34CD-6072-4AD3-A070-1911FB50E52C

Q26747154-20D8D8CC-90EC-464B-A8E7-940564B8DC4B

P2888

Q26747154-D9783314-AB41-4A83-8D94-6CF4B816B0BB

P304

Q26747154-C225F17E-4C05-4F68-ACAC-10BD0A64730F

P31

Q26747154-5EA76299-D467-4DB8-A857-49D9C6C3E891

Q26747154-AB82F540-5E20-41C3-8AD3-50CAD180C13C

P3181

Q26747154-B31CBA30-1DE7-45A7-8AB4-41FC9569A74F

P356

Q26747154-6309D3FD-170E-42AF-A6DB-984CE19E3630

P407

Q26747154-586B057F-8790-45C3-B1B5-366CABFF08B8

P433

Q26747154-77C06164-95D8-4F0F-B1A3-728034FA39CE

P478

Q26747154-E2E1DCF0-D484-4028-8B8A-D547A1A76328

P5008

Q26747154-13E350E1-2E6F-4459-A24E-A5B32A7F8ECD

P577

Q26747154-45B48240-82EB-4769-8DCE-7CAB747AAA96

P6179

Q26747154-EC58F528-E74F-4569-95B8-E2C5646E9740

P698

Q26747154-C7306B3D-665A-4611-A8E4-159C831A8828

P921

Q26747154-275CD12C-FC2B-45F3-8AA7-32ED4D52C0B8

Q26747154-A2618D76-29C6-428A-9C2C-0ADCBB4A1B0B

Q26747154-A9D4F2E0-46CC-418A-A40F-FAD5703B7A17

P932

Q26747154-8E43FE96-63FB-4A40-BD92-4B0A1AE20C48

P3181

P356

S12943-016-0536-0

P1433

Molecular Cancer

P1476

Clinical relevance of circulating cell-free microRNAs in ovarian cancer

@en

P2093

Akihiko Yoshimura

http://www.w3.org/2001/XMLSchema#string

Erika Nakatsuka

http://www.w3.org/2001/XMLSchema#string

Kenjiro Sawada

http://www.w3.org/2001/XMLSchema#string

Koji Nakamura

http://www.w3.org/2001/XMLSchema#string

Tadashi Kimura

http://www.w3.org/2001/XMLSchema#string

Yasuto Kinose

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Identifying microRNA/mRNA dysregulations in ovarian cancer

miR-126 regulates angiogenic signaling and vascular integrity

Secretory mechanisms and intercellular transfer of microRNAs in living cells

Circulating microRNAs as stable blood-based markers for cancer detection.

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

The role of CA125 in clinical practice

Effect of Screening on Ovarian Cancer Mortality

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

Integrated genomic analyses of ovarian carcinoma

Cancer statistics, 2015

P2888

s12943-016-0536-0

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

500372

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12943-016-0536-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029370440

http://www.w3.org/2001/XMLSchema#string

P698

27343009

http://www.w3.org/2001/XMLSchema#string

P921

tumor biomarkers

P932

4921011

http://www.w3.org/2001/XMLSchema#string